MedTrace Logo

Epidemiological Survey of Hepatitis D Virus Infection in China

NCT04483518 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2020-07-23

No results posted yet for this study

Summary

This cross-sectional study will screen out hepatitis D virus-infected patients in HBsAg-positive people. Observe and describe the prevalence of hepatitis D infection among HBsAg positive people. The provinces of China are divided into 5 geographical areas (North, South, East, West and Central) to recruit patients according to the population density of each area. After statistical calculation, the total number of population needed is 3808.

Conditions

  • Observe and Describe the Prevalence of Hepatitis D Infection Among HBsAg Positive People

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • The Fourth Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Ruijin Hospital

    collaborator OTHER

  • The First Hospital of Jilin University

    lead OTHER

Principal Investigators

  • Junqi Niu, Dr. · The First Hospital of Jilin University

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-03
Primary Completion
2020-07-07
Completion
2020-07-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04483518 on ClinicalTrials.gov